Welcome to the SBIR-STTR Resource Center

Right Time, Right Place, Right People

3H Company, LLC is a start-up technology company, located in Lexington, KY. 3H Company's business is in the area of research and development of clean energy technology.

SBIR Funding: Matching Phase I, Matching Phase II

3P Pharmaceuticals seeks to use peptide phage-display to develop biomarkers, research reagents, and therapeutics for multiple diseases and conditions. Our lead therapeutic peptide has been shown to be effective in blocking neuronal cell death and is under investigation in brain injury and related conditions.

SBIR Funding: Phase Zero, Phase Double Zero

Development and Commercialization of Innovative Cutting Edge Welding Technologies

Adaptive Intelligent Systems (AIS) develops and commercializes cutting edge welding technology funded by small business research grants. We offer superior solutions utilizing our unique technologies to our customers to help improve welding productivity and quality.

SBIR Funding: Phase Zero, Phase Double Zero, Matching Phase I, Matching Phase II

Advanced Dynamics is a high-tech firm specializing in 4M modeling and simulation, including aeroelasticity, aeroservoelasticity, aeroservothermoelasticity and propulsion, as well as fluid dynamics, structural mechanics, system dynamics and control, multiphase flows and combustions, etc. As a fast-growing company, Advanced Dynamics is dedicated to the development of 4M Analysis and Optimization software tools for complex mechanical systems, particularly for aerospace vehicles, marine ships and automotives.

SBIR Funding: Phase Zero, Phase Double Zero, Phase I Matching, Phase II

Intranasal Naloxone for Treatment of Suspected Opioid Overdose

Alcomed is developing a medication, intranasally delivered naloxone, for prevention and treatment of overdose from narcotic medications. The intended populations who could receive the product are patients seen by EMS services, pain management patients, those who have recently undergone deotoxification, or those who are maintained on methadone or buprenorphine.

SBIR Funding: Matching Phase I

Putting Life to the Test

ALT BioScience LLC is a privately held diagnostics company located in Lexington, KY. ALT's test strip technology consists of point-of-care diagnostic applications in the detection and monitoring of oral health conditions for professionals and consumers.

SBIR Funding: Phase Zero, Phase Double Zero

AllTranz Inc, a specialty pharmaceutical company based in Lexington, KY will be a leader in the development of innovative pharmaceutical products delivered via unique dermal solutions to treat a variety of neuroscience disorders.

Company's expertise in formulation, prodrug development, and dermal delivery products exploits the opportunity for lower risk development pathways to significant new drugs.

SBIR Funding: Phase Zero, Phase Double Zero, Phase I

Proprietary Natural Products for the Flavor and Fragrance and Insect Repellent Markets

Allylix is focused on the production of natural products called terpenes for the flavor and fragrance and insect repellent markets. Allylix's proprietary technology platform uses the most advanced tools in molecular genetics, biochemistry and structural biology, and fermentation to produce valuable natural products cost effectively.

SBIR Funding: Phase Zero, Phase Double Zero, Phase I Matching

New Patented Transformer Design Improves Energy Efficiency and Reduces Cost to Manufacture

Buswell Energy is an R&D company focused on improvements in transformers and other inductive devices to increase energy efficiency in operation and reduce cost to manufacture. The company has compiled an intellectual property portfolio of eight U.S. patents and will commercialize this technology through licensure to existing manufacturers globally.

SBIR Funding: Phase Zero, Phase Double Zero

Rehabilitation Products for Individuals with Spinal Cord Injury, Stroke, Sports Medicine

customKYnetics Inc. is an early-stage research and development company that focuses on development of rehabilitation engineering products. The primary focus is to design and develop systems that use electrical stimulation in modalities that have the potential to build muscle mass, strength, and endurance or to promote motor retraining.

SBIR Funding: Matching Phase I, Matching Phase II

Direct i2i is a start-up company focusing on high definition video and audio collaboration solutions. Based on over eight years of research by Dr. Ruigang Yang, the company was founded in 2006 with the goal of creating the next generation of teleconferencing systems to allow geographically distributed people to meet and collaborate as if they were in the same room. Initial Funding was provided by the small business technology transfer (STTR) program of the US National Science Foundation and Kentucky Science and Technology Cooperation.

SBIR Funding: Phase Double Zero, Phase I Matching

Innovative Medication Dispenser Solutions to Address Patient Compliance

Dose Control LLC was founded to research, develop, manufacture, and market innovative dispenser solutions to deter prescription drug abuse and increase medication adherence. Our patented device is a programmable, tamper-resistant, portable, refillable dispenser, designed to dispense pills to the patient no faster than the prescribed and programmed rate.

SBIR Funding: Phase Zero, Phase Double Zero

Innovative Biological Reagents for the Life Science Research Market

ECM Biosciences LLC is a life science research company that was founded in 2004 by a team of individuals with over 25 years experience with biological product development, manufacturing, marketing, and distribution. We develop innovative diagnostic tools for research related to cancer, neuropathology, cardiovascular disease, and immune dysfunction.

SBIR Funding: Phase Double Zero, Matching Phase I, Matching Phase II

Devices for Cancer Therapy

Exatherm LLC is dedicated to the development of devices for hyperthermic therapies to treat cancer. The company is planning a clinical trial with lung cancer patients at the University of Kentucky, beginning in January 2012, with a novel whole body circulatory hyperthermia system.

SBIR Funding: Matching Phase II

A Kentucky Company Providing Health and Medical Products Derived from Blackberries

Four Tigers LLC was established in 2005 to develop botanical health and medical products derived from blackberries. Four Tigers is developing a pipeline of blackberry-based health products that will be marketed as a cosmetic (vanishing cream), dietary supplement (oral capsule), and food (chewing gum).

SBIR Funding: Matching Phase I

Providing High Quality Contract Services and Products for Antiviral R&D

IP Pharmaceuticals LLC is dedicated to develop and commercialize novel technologies and reagents for antiviral drug discovery. The company seeks to dis-cover and develop novel therapeutics and vaccines, with a particular emphasis on antiviral drugs to treat infectious diseases caused by viruses such as hepatitis, influenza, West Nile (WNV), Dengue, and respiratory syncytial (RSV) viruses.

SBIR Funding: Phase Zero, Phase Double Zero

Developing Biological Control Methods for Mosquito Control

SBIR Funding: Phase Zero

Natural Products through Genomics

Naprogenix's Natural Product Genomics technology platform reverses the order of traditional high-value chemical discovery by first identifying valuable bio-activity, then tracing it to the underlying chemical agents, and finally optimizing the bioactivity in abundant native and crop plant extracts.

SBIR Funding: Matching Phase I, Matching Phase II

Providing Inovative Solutions for Energy and Environmental Issues

Neathery Technologies Inc. specializes in providing process/product research and development and consulting to firms requiring energy con-version, pollution prevention, process engineering and environmental control expertise.

SBIR Funding: Matching Phase I

The Smallest Materials for the Biggest Impact

nGimat LLC specializes in nanomaterials R&D and manufacturing for the energy, electronics, consumer & biomedical industries. nGimat's proprietary NanoSpray Combustion™ Processing technology and Nanomiser™ Device allow low-cost, high-volume production of nanoEngineered Materials™ with unique performance characteristics.

SBIR Funding: Matching Phase II

Recycling High Quality Ceramics from Coal Combustion Ash

NuForm Materials LLC is company that recycles high quality, value-added ceramics from discarded coal combustion ash. Our process takes raw ash, removes all the contaminants, and classifies it leaving only high quality ceramic particles.

SBIR Funding: Matching Phase I, Matching Phase II

Natural Product-based Treatments for Oral Diseases

Oraceuticals Inc. is engaged in the research, development, and commercialization of drugs, nutraceuticals, natural products, and discoveries that advance oral treatment, improve oral health, and enrich lives. The company's focus is anti-inflammatory, anti-microbial drug development, as well as diagnostics and bioinformatics.

SBIR Funding: Phase Zero, Phase Double Zero, Matching Phase I, Matching Phase II

Developing Technologies Targeting Protein Expression, Natural Insect Control, and Transgenic Technology

ParaTechs Corp. has multiple proprietary technologies under development that address market-proven needs. Brought to market is a proprietary technology derived from insect viruses that enhances protein expression and reduces input costs in bio-manufacturing.

SBIR Funding: Phase Double Zero, Matching Phase I, Matching Phase II

Targeting Alzheimer's Disease

Scout Diagnostics is developing a immunoassay to detect Alzheimer's disease.

A patent covering the test was issued on December 13, 2010. In September 2010, the company received a grant from NIH for $951,000.

SBIR Funding: Matching Phase I, Matching Phase II

Stallion Therapeutics Inc. is a Lexington based start-up pharmaceutical company developing neuroprotective and neurorestorative compounds for traumatic brain injury, spinal cord injury and other acute neurological disorders.

SBIR Funding: Matching Phase I

Developing in situ Nanoparticle Additives for Multifunctional Nanocoatings

Topasol is a pioneering UK start-up company that develops and manufactures additives for multifunctional nanocoatings and was founded in Lexington, Kentucky.

SBIR Funding: Matching Phase I, Matching Phase II

Better Models, Better Results

Transposagen Biopharmaceuticals Inc. is a privately held biotechnology company that is dedicated to providing unique animal models of human diseases for drug discovery and development. Transposagen is focused on providing unique rat models of human disease and on building a novel rat tissue bank to revolutionize drug discovery research.

SBIR Funding: Phase Zero, Phase Double Zero, Matching Phase I, Matching Phase II

Manufacturing a New Type of Paperless Charter Recorders and Hygrometer

Two Dimensional Instruments LLC develops, manufactures, and markets electronic instruments that monitor and alarm for temperature, humidity, and other variables important to the medical, food manufacturing and industrial markets. Our products are used to insure the health of medicines, vaccines, and temperature sensitive raw materials.

SBIR Funding: Phase Zero, Phase Double Zero

Delivering the Future of Nanomedicine

Vindico NanoBioTechnology Inc. is dedicated to the discovery, development and commercialization of highly innovative diagnostic and therapeutic applications based on its proprietary polymersome technology with a focus on the transfusion medicine market.

SBIR Funding: Phase Zero, Matching Phase I

Welcome to the Kentucky SBIR/STTR Resource Center

Conferences and Workshops

Company Spotlight

Contact Us